Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.710
-0.280 (-9.36%)
At close: Jun 5, 2026, 4:00 PM EDT
2.760
+0.050 (1.85%)
After-hours: Jun 5, 2026, 7:58 PM EDT
Editas Medicine Employees
Editas Medicine had 87 employees as of December 31, 2025. The number of employees decreased by 159 or -64.63% compared to the previous year.
Employees
87
Change (1Y)
-159
Growth (1Y)
-64.63%
Revenue / Employee
$444,747
Profits / Employee
-$1,252,345
Market Cap
415.88M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 87 | -159 | -64.63% |
| Dec 31, 2024 | 246 | -19 | -7.17% |
| Dec 31, 2023 | 265 | 39 | 17.26% |
| Dec 31, 2022 | 226 | -38 | -14.39% |
| Dec 31, 2021 | 264 | 29 | 12.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Sutro Biopharma | 133 |
| Neurogene | 131 |
| Ocugen | 116 |
| C4 Therapeutics | 104 |
| Contineum Therapeutics | 51 |
| vTv Therapeutics | 26 |
| Forte Biosciences | 22 |
EDIT News
- 3 days ago - Editas Medicine Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 10 days ago - Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference - GlobeNewsWire
- 11 days ago - Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI - TheFly
- 11 days ago - TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’ - TheFly
- 12 days ago - Editas Medicine 55.6M share Secondary priced at $2.25 - TheFly
- 12 days ago - Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering - GlobeNewsWire
- 12 days ago - Editas Medicine announces common stock, warrant offering, no amount given - TheFly
- 12 days ago - Editas Medicine Announces Proposed Public Offering - GlobeNewsWire